Lecture 79: Antipsychotics Flashcards

1
Q

Typical antipsychotics are pure..

A

Dopamine antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atypical antipsychotics are both…

A

Dopamine antagonists and 5HT2A antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antipsychotics are also called

A

Neuroleptics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

All DA receptors are…

A

G-protein coupled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neuroleptics act on…which is coupled to? This causes

A

D2; Gi; less DA neurotransmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Low potency antipyschotic

A

Clorpromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mid potency antipyschotic

A

Perphenazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

High potency antipyschotics (2)

A

Fluphenazine, haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anitpsychotic “potency” is based on…Why is this important?

A

D2 Blockade; higher potent = less dirty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe “dirty” SEs of antipsychotics via receptors

A

ACh, H1, alpha1 blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Therapeutic use of antipsychotics (5)

A

Primary and secondary psychotic disorder, mood disorders (bipolar and MDD w/ psychotic features), severe agitation, delirium, Tourette’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What drugs are available once-a-month dosing?

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DA-related effects of antipsychotics and pathway

A
  1. Parkinsonian-like (nigrostriatal); 2. Relief of psychosis (mesolimbic); 3. Increased negative symptoms (mesocortical); 4. Elevated prolactin –> breast enlargement/lactation (tuberoinfundibular pathway)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neurological adverse effects (3). Which drugs convey highest risk?

A
  1. Extrapyramindal symptoms (EPS; Parkinsonism, acute dystonia, akathisia); 2. Tardive dyskineasia; 3. Neuroleptic malignant syndrome; high potency drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many patients get neuroleptic-induced Parkisonism (%)? When do they occur? What is treatment? Why?

A

15%; within several months; anticholinergics –> typically balance b/t DA and ACh, if you block DA, you should block ACh to re-achieve balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe acute dystonic reaction: symptoms, when it occurs, treatment

A

Spastic contractions in face and body; occurs quickly (within days); anticholinergic

17
Q

Describe akathisia: symptoms

A

Subjective feeling of inner restlessness w/ objective increased motor activity

18
Q

Describe tardive dyskinesia: symptoms, onset (%), treatment

A

Writhing movements of mostly face; 5%/year (long-term use); not reversible –> stopping/switching antipsychotic

19
Q

Describe neuroleptic malignant syndrome: symptoms, onset time, mortality (%)

A

Autonomic symptoms (fever, sweating), motor & behavior symptoms (rigidity, dystonia, agitation, confusion); can occur ANY TIME; 20-30% if untreated

20
Q

Other antipsychotic SEs by 3 receptors and 1 other important SE

A

M1, H1, alpha1 receptor blockade; cardiac (QT prolongation)

21
Q

Atypical antipsychotics

A

Clozapine, risperidone, olazapine, ziprasidone, quetiapine, aripiprazole

22
Q

What makes an antipsychotic atypical (2)

A
  1. D2 AND 5HT2A antagonists; 2. Rapid dissociation from D2 receptor
23
Q

Why does 5HT2A antagonism work? How does it work in real patients?

A

Turns off GABA interneuron –> more DA release (tempering DA blockade); complicated net actions on DA activity, varies per patient

24
Q

Theoretical benefits of atypicals and which are true/not true (4)

A

Reduced EPS (true), reduced hyperprolactinemia (true), cognitive enhancement (not true), improved adherence (not true)

25
Q

How to choose an antipsychotic? Example.

A

Look at receptor binding profile (i.e. olazapine blocks H1 more than risperidone, so it is more sedating, good for agitated people)

26
Q

Therapeutic use of antipsychotics (3)

A
  1. Psychotic disorders; 2. Mood disorders w/ psychotic features; 3. Treatment resistant MDD; 4. Aggression/irritability in children with autism (Risperidone)
27
Q

T/F: Atypicals are associated with off-label uses

A

True! Multiple

28
Q

How is Aripiprazole different?

A

“Third generation” –> partial agonist at DA D2 receptor and 5-HT1A; antagonist at 5-HT2A

29
Q

What is the most effective AND drug of choice for treatment resistant schizophrenia? What’s interesting about this drug and why is it not always first line?

A

Clozapine; low potency as D2-receptor antagonist; potentially irreversible risk of agranulocytosis

30
Q

Risperidone has similar SEs to…why?

A

Typicals because it is a strong blocker of D2

31
Q

Adverse effect of atypical antipsychotics

A

Metabolic syndrome: visceral obesity, low insulin resistance, high triglycerides, hypertension low HDL-cholesterol

32
Q

Mortality with atypical antipsychotics

A

2-3x increased mortality from all causes

33
Q

What are the “worst” atypicals for metabolic syndrome. Best?

A

Clozapine and olanzapine; aripiprazole

34
Q

Other adverse effects of antipsychotics

A

Cardiac, sedation, EPS (risperidone), seizures…

35
Q

Rare serious SEs of clozapine

A

Agranulocytosis and myocarditis

36
Q

What is a common off label use of antipsychotics? Good data? Why is this concerning?

A

Treat behavioral disturbances in ELDERLY; NO; can cause over sedation/falls (orthostatic hypotension), increases ALL CAUSES of mortality

37
Q

The only two antispychotics shown to increase cognition/social life. But these are…Why?

A

Clozapine and olanzapine; 2nd line; more likely to induce metabolic syndrome (and scary SEs)

38
Q

Why do we use atypical antipsychotics first line?

A

You CAN treat metabolic syndrome but NOT tardive dyskinesia